Gossamer Bio, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Gossamer Bio, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

Q2 2025

Aug 5, 2025

Earnings release8-K

Quarterly report10-Q

Q1 2025

May 15, 2025

Earnings release8-K

Quarterly report10-Q

Transcript

2024

Q4 2024

Mar 13, 2025

Earnings release8-K

Q3 2024

Nov 7, 2024

Earnings release8-K

Quarterly report10-Q

Corporate Presentation 2024

Aug 14, 2024

Slides

Q2 2024

Aug 12, 2024

Earnings release8-K

Q1 2024

May 7, 2024

Earnings release8-K

M&A Announcement

May 6, 2024

Press release

Slides

Collaboration with Chiesi Farmaceutici S.p.A. 2024

May 6, 2024

Slides

2023

Q4 2023

Mar 5, 2024

Annual report10-K

Earnings release8-K

Study Update 2023

Dec 18, 2023

Slides

Q3 2023

Nov 9, 2023

Earnings release8-K

Q2 2023

Aug 8, 2023

Earnings release8-K

Status Update 2023

Jul 25, 2023

Slides

Q1 2023

May 9, 2023

Earnings release8-K

Study Result 2023

Dec 6, 2022

Slides

2022

Q4 2022

Mar 17, 2023

Annual report10-K

Earnings release8-K

Q3 2022

Nov 3, 2022

Earnings release8-K

Q2 2022

Aug 9, 2022

Earnings release8-K

Q1 2022

May 10, 2022

Earnings release8-K

2021

Q4 2021

Mar 3, 2022

Annual report10-K

Earnings release8-K

Q3 2021

Nov 8, 2021

Earnings release8-K

Investor Day 2021

Oct 11, 2021

Slides

Q2 2021

Aug 9, 2021

Earnings release8-K

Slides

Q1 2021

May 6, 2021

Earnings release8-K

2020

Q4 2020

Feb 26, 2021

Annual report10-K

2019

Q4 2019

Mar 24, 2020

Annual report10-K

2018

Q4 2018

Mar 22, 2019

Annual report10-K